ALPS MEDICAL BREAKTHROUGHS ETF - USD |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 41.65 USD | -0.42% |
|
-.--% | -.--% |
Investment objective
The ALPS Medical Breakthroughs ETF invests in the public equity markets of the United States. It invests in the stocks of companies operating in the biotechnology and pharmaceutical sectors. The fund invests in stocks of mid cap and small cap companies with a market capitalization of no less than $200 million and no more than $5 billion. It seeks to replicate the performance of the S-Network Medical Breakthroughs Index, by investing in the stocks of companies as per their weightings in the index.
| Name |
Price
|
Change
|
5d. change
|
1st Jan change
|
Weight
| |
|---|---|---|---|---|---|---|
| 31.76 USD | +0.16% | -2.55% | +38.51% | -.--% | ||
| 33.72 USD | -4.29% | -5.09% | +119.25% | -.--% | ||
| 7.31 USD | -7.00% | -12.98% | -34.56% | -.--% | ||
| 25.87 USD | +5.76% | +4.23% | -37.15% | -.--% | ||
| 75.05 USD | +0.74% | +3.88% | +19.51% | 4.03% | ||
| 38.96 USD | -1.52% | -6.91% | -8.11% | 4.03% | ||
| 15.5 USD | -0.64% | +4.24% | -50.50% | 3.42% | ||
| 38.42 USD | -1.06% | +1.86% | +33.96% | 3.18% | ||
| 24.57 USD | +1.61% | +0.61% | -11.43% | 3.17% | ||
| 77.12 USD | -2.39% | +1.45% | -3.10% | 2.52% | ||
More news
In partnership with
ETF Ratings
 |
Description
| US00162Q5936 | |
|---|---|
| Total Expense Ratio | 0.50% |
| Asset Class | |
| Sector | |
| Size | |
| Currency | |
| Provider | |
| Underlying | S-Network Medical Breakthroughs Index NTR - USD |
Features and characteristics
| Jurisdiction | |
| Fund Structure | |
| Replication Method | |
| Replication Model | |
| Date of creation |
29/12/2014
|
| Dividend Policy | |
| Geographical Focus |
AuM evolution ( 30/05/2024 )
| AuM (EUR) | 95 M€ |
|---|---|
| AuM 1M | 101 M€ |
| AuM 3 months | 113 M€ |
| AuM 6 months | 79 M€ |
| AuM 12 months | 106 M€ |
- Stock Market
- ETF
- 0H6M ETF
